Abstract: It is not uncommon that real-world data are distributed with a long tail. For such data, the learning of deep neural networks becomes challenging because it is hard to classify tail classes ...
Fewer than one in ten people who could benefit from weight loss jabs can access them due to high costs and supply issues associated with the medication, the World Health Organisation (WHO) has warned.
Molly Bowcott joined C+D as a digital reporter in October 2024 after graduating from a master’s in journalism at City, University of London. She previously worked as a news reporter at the U.S. Sun, ...
Weight loss injections have been conditionally recommended for treating obesity by the World Health Organization (WHO) for the first time. WHO Director-General Tedros Adhanom Ghebreyesus said the new ...
WHO recommends weight loss jabs to treat obesity around the world The drugs could be ‘transformative’ in fighting obesity, which will affect two billion people globally by 2030, says health agency ...
Fewer than one in 10 people who could benefit from obesity jabs like Wegovy are able to get them, warns the World Health Organization, external as it releases its first guidance on the drugs. With ...
Gabriela, pictured here, says she "tried everything" from stricter dieting to intense workouts six days a week but "nothing worked" Gabriela was trying to lose the weight she'd gained during the Covid ...
Gabriela was trying to lose the weight she'd gained during the Covid pandemic. But a few stubborn kilos just wouldn't budge. She had tried everything, she says. Going on a stricter diet; being more ...
Read on to find out which royal Jane would love to see on I'm A Celeb ROBBIE WILLIAMS and I had a bit of a public disagreement in the past, over my comments about his Netflix show. But when it comes ...
There's no doubt that weight-loss jabs such as Mounjaro and Wegovy have completely revolutionised the diet industry. But thanks to price hikes, the truth is that not everyone who would like to shift ...
A new generation of weight-loss ‘super-jabs’ could help those who struggle to ditch the pounds with existing drugs, such as semaglutide and tirzepatide. The new treatments are designed to give a ...